« Return to News | CROs/Service Providers | Technology Solutions

Bio-Imaging Technologies Sells CapMed Division

Thursday, January 8, 2009 09:44 AM

Contract research organization (CRO) Bio-Imaging Technologies has sold off its CapMed division, which provides personal health management solutions to hospitals, employers and pharmaceutical companies, in order to better focus on the CRO’s core clinical trials business.

Under the terms of the agreement, Bio-Imaging will receive $500,000 in cash plus an earn-out over a two-year period from Metavante Technologies, a Milwaukee-based provider of banking and payment technologies.

“We believe that it is beneficial for all parties that CapMed will be a part of an organization that is more closely aligned with healthcare information and payment processing for consumers,” Bio-Imaging president and CEO Mark Weinstein said in a company release.

Bio-Imaging expects to incur a one-time charge of $2.5 to $2.7 million related to the write-down of assets of the CapMed division. As a result, the company has lowered its full year 2008 earnings per share guidance from a range of $0.23 to $0.25 per share to a range of $0.11 to $0.15 per share.

In early morning trading, Bio-Imaging’s share prices were up 2.56% to $3.20.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.